A Case-Control Study of Risk Factors of Abdominal Aortic Aneurysm
AbstractObjective: To explore the potential risk factors of abdominal aortic aneurysm (AAA) in the Chinese population.
Methods: A matched case-control study was designed for the study. Patients with AAA administrated in the First Affiliated Hospital of Zhengzhou University from January 2005 to December 2007 were included in the study. Sex and age-matched volunteers were selected for the case-control in the same period. A uniform questionnaire was sent to patients and volunteers to collect demographic data, past medical history, and behavioral factors. General physical examination, ultrasound examination of the abdominal aorta, and serological testing were used to collect clinical data. Environmental risk factors of abdominal aortic aneurysms were analyzed by conditional logistic regression.
Results: A total of 465 subjects including 155 patients were enrolled in the study. Multivariate regression analysis found that people with high blood pressure have high risk of AAA (OR = 1.88, 95% CI 1.12-3.18; P = .02). Smoking is a significant independent risk factor for AAA; the morbidity of AAA in smokers is 5.23-fold of non-smokers (95% CI 2.44-11.23). Dyslipidemia (OR = 2.61, 95% CI 1.45-4.70), serum high sensitivity C-reactive protein (OR = 2.43, 95% CI 1.37-4.31), and homocysteine (OR = 2.73, 95% CI 1.61-4.65) were valuable parameters in detecting AAA.
Conclusion: Hypertension and smoking are risk factors of abdominal aortic aneurysms; dyslipidemia, high-sensitivity C-reactive protein, and homocysteine levels are associated with AAA.
Agroyannis, B., A. Chatziioannou, D. Mourikis, et al. (2002). “Abdominal aortic aneurysm and renal artery stenosis: renal function and blood pressure before and after endovascular treatment.” J Hum Hypertens 16(5): 367-369.
Badger, S. A., M. E. O’Donnell, M. A. Sharif, et al. (2009). “The role of smoking in abdominal aortic aneurysm development.” Angiology 60(1): 115-119.
Basso, R. D., T. Sandgren, A. R. Ahlgren and T. Lanne (2015). “Increased cardiovascular risk without generalized arterial dilating diathesis in persons who do not have abdominal aortic aneurysm but who are first-degree relatives of abdominal aortic aneurysm patients.” Clin Exp Pharmacol Physiol 42(6): 576-581.
Bath, M. F., V. J. Gokani, D. A. Sidloff, et al. (2015). “Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm.” Br J Surg 102(8): 866-872.
Bird, A. N. and A. M. Davis (2015). “Screening for abdominal aortic aneurysm.” JAMA 313(11): 1156-1157.
Eugster, T., A. Huber, T. Obeid, et al. (2005). “Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm.” Eur J Vasc Endovasc Surg 29(4): 378-382.
Forsdahl SH, Singh K, Solberg S, Jacobsen BK. 2009. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the TromsÃ¸ Study, 1994-2001. Circulation 119:2202-8.
Jacob, A. D., P. L. Barkley, K. C. Broadbent et al. (2015). “Abdominal aortic aneurysm screening.” Semin Roentgenol 50(2): 118-126.
Johansson, M., A. Hansson and J. Brodersen (2015). “Estimating overdiagnosis in screening for abdominal aortic aneurysm: could a change in smoking habits and lowered aortic diameter tip the balance of screening towards harm?” BMJ 350: h825.
Kaneko, H., T. Anzai, K. Horiuchi, et al. (2011). “Tumor necrosis factor-alpha converting enzyme is a key mediator of abdominal aortic aneurysm development.” Atherosclerosis 218(2): 470-478.
Khashram, M., G. T. Jones and J. A. Roake (2015). “Prevalence of Abdominal Aortic Aneurysm (AAA) in a Population Undergoing Computed Tomography Colonography in Canterbury, New Zealand.” Eur J Vasc Endovasc Surg.
Koole, D., F. L. Moll, J. Buth, R. Hobo, et al. (2012). “The influence of smoking on endovascular abdominal aortic aneurysm repair.” J Vasc Surg 55(6): 1581-1586.
Liu, Z., H. Luo, L. Zhang, et al. (2012). “Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice.” Circ Res 111(10): 1261-1273.
Maegdefessel, L., J. Azuma, R. Toh, et al. (2012). “MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion.” Sci Transl Med 4(122): 122ra122.
Meijer, C. A., V. B. Kokje, R. B. van Tongeren, et al. (2012). “An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study.” Eur J Vasc Endovasc Surg 44(2): 153-157.
Parmar, G. M., B. Lowman, B. R. Combs, et al. (2013). “Effect of lipid-modifying drug therapy on survival after abdominal aortic aneurysm repair.” J Vasc Surg 58(2): 355-363.
Powell, J. T., B. R. Muller and R. M. Greenhalgh (1987). “Acute phase proteins in patients with abdominal aortic aneurysms.” J Cardiovasc Surg (Torino) 28(5): 528-530.
Sharif, M. A., D. A. McDowell and S. A. Badger (2013). “Chlamydia pneumoniae antibodies and C-reactive protein levels in patients with abdominal aortic aneurysms.” ScientificWorldJournal 2013: 212450.
Stackelberg, O., M. Bjorck, S. C. Larsson, et al.(2014). “Alcohol consumption, specific alcoholic beverages, and abdominal aortic aneurysm.” Circulation 130(8): 646-652.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).